Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127808882 | 12780888 | 2 | F | 20160728 | 20160916 | 20160926 | 20160930 | EXP | IT-APOTEX-2016AP011948 | APOTEX | 32.63 | YR | F | Y | 0.00000 | 20160930 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127808882 | 12780888 | 1 | PS | QUETIAPINA DOC GENERICI COMPRESSE RIVESTITE CON FILM | QUETIAPINE | 1 | Oral | UNK | D | 90960 | TABLET | ||||||||
| 127808882 | 12780888 | 2 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | UNK | D | 0 | |||||||||
| 127808882 | 12780888 | 3 | SS | ENTACT | ESCITALOPRAM OXALATE | 1 | Oral | UNK | D | 0 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127808882 | 12780888 | 1 | Depression |
| 127808882 | 12780888 | 2 | Depression |
| 127808882 | 12780888 | 3 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127808882 | 12780888 | OT |
| 127808882 | 12780888 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127808882 | 12780888 | Coma | |
| 127808882 | 12780888 | Drug abuse | |
| 127808882 | 12780888 | Psychomotor hyperactivity | |
| 127808882 | 12780888 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |